Literature DB >> 31693861

Growth differentiation factor 15 and its role in carcinogenesis: an update.

Anupama Modi1, Shailender Dwivedi1, Dipayan Roy1, Manoj Khokhar1, Purvi Purohit1, Jeewanram Vishnoi2, Puneet Pareek3, Shailja Sharma1, Praveen Sharma1, Sanjeev Misra2.   

Abstract

Growth differentiation factor-15 (GDF-15) is a novel cytokine secreted by a variety of cells like macrophages, adipocytes, normally expressed in high amounts by placenta. It is also highly expressed in multiple carcinomas like Colon, Breast, Pancreas, Liver, and Ovarian. Several reports on serum GDF-15 as a potential biomarker for diagnosis and prognosis of cancer are hampered by the lack of robust data, with large sample size and critical patient recruitment. However, experimental accounts on cancer tumors, cell lines, and animal models suggest GDF-15's role in cancer progression via endothelial mesenchymal transition, angiogenesis, metastasis, drug resistance and even stemness of various cancers. GDF-15 could be the point of amalgamation for the various hallmarks of cancer and can prove a useful therapeutic target in cancer. The current review was conceptualized with a thought of critically appraising the existing information of GDF-15 in carcinogenesis.

Entities:  

Keywords:  Growth differentiation factor-15; angiogenesis; drug resistance; endothelial mesenchymal transition; metastases; radio-resistance; stemness

Mesh:

Substances:

Year:  2019        PMID: 31693861     DOI: 10.1080/08977194.2019.1685988

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  11 in total

1.  FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer.

Authors:  Anupama Modi; Purvi Purohit; Dipayan Roy; Jeewan Ram Vishnoi; Puneet Pareek; Poonam Elhence; Priyanka Singh; Shailja Sharma; Praveen Sharma; Sanjeev Misra
Journal:  Mol Biol Rep       Date:  2022-01-23       Impact factor: 2.316

Review 2.  The Role of Growth Differentiation Factor 15 in Energy Metabolism.

Authors:  Joon Young Chang; Hyun Jung Hong; Seul Gi Kang; Jung Tae Kim; Ben Yuan Zhang; Minho Shong
Journal:  Diabetes Metab J       Date:  2020-06       Impact factor: 5.376

Review 3.  Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.

Authors:  Jörg Wischhusen; Ignacio Melero; Wolf Herman Fridman
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

Review 4.  GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer.

Authors:  Darakhshan Sohail Ahmed; Stéphane Isnard; John Lin; Bertrand Routy; Jean-Pierre Routy
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

5.  Growth Differentiation Factor 15: A Biomarker with High Clinical Potential in the Evaluation of Kidney Transplant Candidates.

Authors:  Marina de Cos Gomez; Adalberto Benito Hernandez; Maria Teresa Garcia Unzueta; Jaime Mazon Ruiz; Covadonga Lopez Del Moral Cuesta; Jose Luis Perez Canga; David San Segundo Arribas; Rosalia Valero San Cecilio; Juan Carlos Ruiz San Millan; Emilio Rodrigo Calabia
Journal:  J Clin Med       Date:  2020-12-20       Impact factor: 4.241

Review 6.  A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan.

Authors:  Ibrahim Mohammed; Morley D Hollenberg; Hong Ding; Chris R Triggle
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-05       Impact factor: 5.555

7.  A Combined Analysis of Serum Growth Differentiation Factor-15 and Cancer Antigen 15-3 Enhances the Diagnostic Efficiency in Breast Cancer.

Authors:  Anupama Modi; Purvi Purohit; Ashita Gadwal; Dipayan Roy; Sujoy Fernandes; Jeewan Ram Vishnoi; Puneet Pareek; Poonam Elhence; Sanjeev Misra; Praveen Sharma
Journal:  EJIFCC       Date:  2021-10-18

8.  Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications.

Authors:  Nuria Carmona-Ule; Miriam González-Conde; Carmen Abuín; Juan F Cueva; Patricia Palacios; Rafael López-López; Clotilde Costa; Ana Belén Dávila-Ibáñez
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

Review 9.  The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer.

Authors:  Yichi Xu; Gendi Song; Shangdan Xie; Wenxiao Jiang; Xin Chen; Man Chu; Xiaoli Hu; Zhi-Wei Wang
Journal:  Mol Ther       Date:  2021-04-29       Impact factor: 12.910

10.  Cellular and Intercellular Homeostasis in Adipose Tissue with Mitochondria-Specific Stress.

Authors:  Min Jeong Choi; Saet-Byel Jung; Joon Young Chang; Minho Shong
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.